The Magazine for Sleep Professionals
Friday, August 28, 2026
As America prepares to observe Veterans Day in honor of those who served, fought, and died for us, AirAvant Medical and First Nation Group announce a partnership alliance providing the FDA-cleared Bongo® Rx Expiratory Positive Airway Pressure (EPAP) device to Veterans and active-duty military members suffering from Obstructive Sleep Apnea (OSA). The partnership between First Nation […]
Bongo Rx, an FDA cleared medical device for the treatment of mild to moderate obstructive sleep apnea, utilizes no electricity or batteries. This cutting edge medical technology reduces the carbon footprint in the battle against global warming as no fossil fuels are consumed to power the device during use. […]
According to a recent Qualtrics Survey conducted September 4th through September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their sleep apnea when given the choice. The Bongo […]
The AirAvant Medical team is looking forward to sharing their poster findings with the attendees at the SLEEP 2019 conference in San Antonio on June 8-12. The opportunity to engage with industry experts, doctors, and providers is sure to generate even more clinical interest in using the Bongo Rx, an […]
AirAvant Medical is proud to announce that its flagship product, FDA Cleared Bongo Rx, is now available for patients requiring treatment of mild to moderate obstructive sleep apnea (OSA). Years of painstaking research, development, and testing have yielded a device that is small, portable, and best of all requires no […]
AirAvant Medical has announced that its flagship product, the Bongo Rx, has received its FDA 510(k) Clearance for the treatment of mild to moderate obstructive sleep apnea (OSA). Years of painstaking research, development, and testing have yielded a device that is small, portable, and best of all requires no CPAP […]
